{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T01:28:46Z","timestamp":1785806926619,"version":"3.56.0"},"reference-count":21,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2011,12,1]],"date-time":"2011-12-01T00:00:00Z","timestamp":1322697600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2011,12]]},"DOI":"10.1016\/j.vaccine.2011.06.089","type":"journal-article","created":{"date-parts":[[2011,12,18]],"date-time":"2011-12-18T15:53:06Z","timestamp":1324223586000},"page":"D111-D115","source":"Crossref","is-referenced-by-count":12,"special_numbering":"S4","title":["Vaccines of the future"],"prefix":"10.1016","volume":"29","author":[{"given":"G.J.V.","family":"Nossal","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2011.06.089_bib0005","doi-asserted-by":"crossref","first-page":"6305","DOI":"10.1016\/j.vaccine.2008.09.040","article-title":"The cost-effectiveness of typhoid Vi vaccination programs: calculations for four urban sites in four Asian countries","volume":"26","author":"Cook","year":"2008","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2011.06.089_bib0010","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1016\/j.mib.2004.04.008","article-title":"Bacterial genomes pave the way to novel vaccines","volume":"7","author":"Meinke","year":"2004","journal-title":"Curr Opin Microbiol"},{"issue":"18","key":"10.1016\/j.vaccine.2011.06.089_bib0015","doi-asserted-by":"crossref","first-page":"1737","DOI":"10.1056\/NEJMoa022823","article-title":"Decline in invasive pneumococcal disease after the introduction of protein-polysaccharide conjugate vaccine","volume":"348","author":"Whitney","year":"2003","journal-title":"New Engl J Med"},{"issue":"March (9)","key":"10.1016\/j.vaccine.2011.06.089_bib0020","first-page":"258","article-title":"Licensure of a 13-valent pneumococcal conjugate vaccine (PCV13) and recommendations for use among children\u2014Advisory Committee on Immunization Practices (ACIP), 2010","volume":"59","author":"Centers for Disease Control and Prevention (CDC)","year":"2010","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"Suppl. 3","key":"10.1016\/j.vaccine.2011.06.089_bib0025","doi-asserted-by":"crossref","first-page":"S26","DOI":"10.1186\/1471-2458-11-S3-S26","article-title":"An evaluation of emerging vaccines for childhood pneumococcal pneumonia","volume":"11","author":"Webster","year":"2011","journal-title":"BMC Public Health"},{"issue":"3","key":"10.1016\/j.vaccine.2011.06.089_bib0030","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1111\/j.1365-3083.2008.02225.x","article-title":"IC31, a two-component novel adjuvant mixed with a conjugate vaccine enhances protective immunity against pneumococcal disease in neonatal mice","volume":"69","author":"Olafsdottir","year":"2009","journal-title":"Scand J Immunol"},{"issue":"8","key":"10.1016\/j.vaccine.2011.06.089_bib0035","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1086\/444458","article-title":"Safety and immunogenicity of 26-valent group a streptococcus vaccine in healthy adult volunteers","volume":"41","author":"McNeil","year":"2005","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.vaccine.2011.06.089_bib0040","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1056\/NEJMoa0904797","article-title":"Effect of human rotavirus vaccine on severe diarrhea in African infants","volume":"362","author":"Madhi","year":"2010","journal-title":"New Engl J Med"},{"key":"10.1016\/j.vaccine.2011.06.089_bib0045","doi-asserted-by":"crossref","first-page":"2521","DOI":"10.1056\/NEJMoa0807381","article-title":"Efficacy of RTS,S\/AS01E vaccine against malaria in children 5 to 17 months of age","volume":"359","author":"Bejon","year":"2008","journal-title":"New Engl J Med"},{"key":"10.1016\/j.vaccine.2011.06.089_bib0050","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1016\/j.pt.2008.08.008","article-title":"Recent insights into humoral and cellular immune responses against malaria","volume":"24","author":"Beeson","year":"2008","journal-title":"Trends Parasitol"},{"key":"10.1016\/j.vaccine.2011.06.089_bib0055","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1016\/j.ijpara.2010.04.008","article-title":"Merozoite surface proteins of the malaria parasite: the MSP1 complex and the MSP7 family","volume":"40","author":"Kadekoppala","year":"2010","journal-title":"Int J Parasitol"},{"key":"10.1016\/j.vaccine.2011.06.089_bib0060","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1038\/nature00937","article-title":"as a candidate anti-toxic vaccine in a model of malaria","volume":"418","author":"Schofield","year":"2002","journal-title":"Nature"},{"key":"10.1016\/j.vaccine.2011.06.089_bib0065","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1086\/339409","article-title":"Protection of humans against malaria by immunization with radiation-attenuated Plasmodium falciparum sporozoites","volume":"185","author":"Hoffmann","year":"2002","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2011.06.089_bib0070","doi-asserted-by":"crossref","first-page":"107","DOI":"10.4161\/hv.6.1.9654","article-title":"Genetically engineered, attenuated whole-cell vaccine approaches for malaria","volume":"6","author":"Vaughan","year":"2010","journal-title":"Hum Vaccin"},{"key":"10.1016\/j.vaccine.2011.06.089_bib0075","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1016\/S0140-6736(02)09784-2","article-title":"Immunity to malaria after administration of ultra-low doses of red cells infected with Plasmodium falciparum","volume":"360","author":"Pombo","year":"2002","journal-title":"Lancet"},{"key":"10.1016\/j.vaccine.2011.06.089_bib0080","doi-asserted-by":"crossref","first-page":"2209","DOI":"10.1056\/NEJMoa0908492","article-title":"Vaccination with ALVAC and AIDSVAX to prevent HIV-1 infection in Thailand","volume":"361","author":"Rerks-Ngarm","year":"2009","journal-title":"N Engl J Med"},{"key":"10.1016\/j.vaccine.2011.06.089_bib0085","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1016\/j.coi.2010.02.012","article-title":"Rational antibody-based HIV-1 vaccine design: current approaches and future directions","volume":"22","author":"Walker","year":"2010","journal-title":"Curr Opin Immunol"},{"key":"10.1016\/j.vaccine.2011.06.089_bib0090","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1016\/j.coi.2010.04.006","article-title":"Novel tuberculosis vaccines on the horizon","volume":"22","author":"Parida","year":"2010","journal-title":"Curr Opin Immunol"},{"key":"10.1016\/j.vaccine.2011.06.089_bib0095","doi-asserted-by":"crossref","unstructured":"Harrison LC. Vaccination for autoimmune and other chronic inflammatory disorders. In Levine MM, editor. New generation vaccines, 4th edn. New York, NY: Informa Health Care. p. 969\u201381.","DOI":"10.3109\/9781420060744-89"},{"key":"10.1016\/j.vaccine.2011.06.089_bib0100","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.3001012","article-title":"Comprehensive, quantitative mapping of T cell epitopes in gluten in celiac disease","author":"Tye-Din","year":"2010","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.vaccine.2011.06.089_bib0105","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1097\/PPO.0b013e3181a7450f","article-title":"Recent advances using anti-CTLA-4 for the treatment of melanoma","volume":"15","author":"Sarnaik","year":"2009","journal-title":"Cancer J"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X11009832?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X11009832?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2021,12,20]],"date-time":"2021-12-20T18:56:41Z","timestamp":1640026601000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X11009832"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,12]]},"references-count":21,"alternative-id":["S0264410X11009832"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2011.06.089","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2011,12]]}}}